Ashfield Capital Partners, LLC Bristol Myers Squibb CO Transaction History

Ashfield Capital Partners, LLC

$1.19 Billion
Q3 2022

A detailed history of Ashfield Capital Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ashfield Capital Partners, LLC holds 90,339 shares of BMY stock, worth $5.35 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

90,339

Previous 92,431 2.26%

Holding current value

$5.35 Million

Previous $7.12 Million 9.77%

% of portfolio

0.54%

Previous 0.55%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $271 - $160,749	-2,092 Reduced 2.26%	90,339 $6.42 Million
Q2 2022 Jul 29, 2022	SELL	$72.62 - $79.98 $46,767 - $51,507	-644 Reduced 0.69%	92,431 $7.12 Million
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $27,420 - $32,879	446 Added 0.48%	93,075 $6.8 Million
Q4 2021 Feb 02, 2022	SELL	$53.63 - $62.52 $208,138 - $242,640	-3,881 Reduced 4.02%	92,629 $5.78 Million
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $38,282 - $44,843	-647 Reduced 0.67%	96,510 $5.71 Million
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $34,360 - $37,418	-555 Reduced 0.57%	97,157 $6.49 Million
Q1 2021 May 11, 2021	BUY	$59.34 - $66.74 $85,330 - $95,972	1,438 Added 1.49%	97,712 $6.17 Million
Q4 2020 Feb 02, 2021	SELL	$57.74 - $65.43 $606,154 - $686,884	-10,498 Reduced 9.83%	96,274 $5.97 Million
Q3 2020 Nov 03, 2020	SELL	$57.43 - $63.64 $137,774 - $152,672	-2,399 Reduced 2.2%	106,772 $6.44 Million
Q2 2020 Aug 05, 2020	BUY	$54.82 - $64.09 $3.84 Million - $4.49 Million	70,067 Added 179.18%	109,171 $6.42 Million
Q1 2020 May 06, 2020	SELL	$46.4 - $67.43 $122,496 - $178,015	-2,640 Reduced 6.32%	39,104 $2.18 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $784,899 - $1.02 Million	15,950 Added 61.84%	41,744 $2.68 Million
Q2 2019 Jul 29, 2019	SELL	$44.62 - $49.34 $13,386 - $14,802	-300 Reduced 1.15%	25,794 $1.17 Million
Q1 2019 Apr 30, 2019	SELL	$45.12 - $53.8 $19,401 - $23,134	-430 Reduced 1.62%	26,094 $1.25 Million
Q4 2018 Feb 13, 2019	BUY	$48.76 - $63.23 $20,966 - $27,188	430 Added 1.65%	26,524 $1.38 Million
Q2 2018 Jul 26, 2018	SELL	$50.53 - $62.98 $8,438 - $10,517	-167 Reduced 0.64%	26,094 $1.44 Million
Q1 2018 May 02, 2018	BUY	$59.92 - $68.98 $10,006 - $11,519	167 Added 0.64%	26,261 $1.66 Million
Q4 2017 Feb 13, 2018	SELL	$59.94 - $65.35 $1,018 - $1,110	-17 Reduced 0.07%	26,094 $1.6 Million
Q3 2017 Nov 07, 2017	SELL	$55.23 - $63.74 $8,174 - $9,433	-148 Reduced 0.56%	26,111 $1.66 Million
Q2 2017 Aug 14, 2017	BUY	N/A	26,259	26,259 $1.46 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashfield Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashfield Capital Partners, LLC with notifications on news.

Account

Ashfield Capital Partners, LLC Bristol Myers Squibb CO Transaction History